Skip to main content

Advertisement

SpringerLink
Log in

Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The intravenous injection of vinorelbine often causes venous irritation such as erythema, injection site pain, and phlebitis. The purpose of the present study was to investigate the risk factor associated with the vinorelbine-induced venous irritation and to establish a suitable administration method of vinorelbine.

Methods

We analyzed the risk factor associated with venous irritation in 63 patients administered vinorelbine from April 2006 to September 2008. We subsequently changed the regimen of vinorelbine and examined the incidence of venous irritation in 24 patients administered vinorelbine from October 2008 to March 2010.

Results

A multivariate logistic regression analysis revealed that the dose of vinorelbine (≥40 mg) was a significant predictor for venous irritation (adjusted odds ratio = 4.39; 95% confidence intervals, 1.33–14.49; p = 0.015). Moreover, the grade of venous irritation in patients administered vinorelbine at the doses of ≥40 mg was significantly higher than that in patients administered vinorelbine at the doses of <40 mg (p = 0.011). Based on this result, we altered the volume of normal saline for vinorelbine dissolution from 50 to 100 mL. After the change of regimen, the grade of venous irritation induce by vinorelbine was significantly decreased (p = 0.034), although the incidence was not significantly changed (46.0% versus 33.3%).

Conclusions

The change of regimen of vinorelbine based on the analysis significantly decreased the grade of venous irritation. Pharmacists can contribute to the management for the vinorelbine-induced venous irritation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Winton T, Livingston R, Johnson D et al (2005) Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352:2589–2597

    Article  PubMed  CAS  Google Scholar 

  2. Romero A, Rabinovich MG, Vallejo CT et al (1994) Vinorelbine as first-line chemotherapy for metastatic breast carcinoma. J Clin Oncol 12:336–341

    PubMed  CAS  Google Scholar 

  3. Pérol M, Guérin JC, Thomas P et al (1996) Multicenter randomized trial comparing cisplatin–mitomycin–vinorelbine versus cisplatin–mitomycin–vindesine in advanced non-small cell lung cancer. Lung cancer 14:119–134

    Article  PubMed  Google Scholar 

  4. Rittenberg CN, Gralla RJ, Rehmeyer TA (1995) Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine). Oncol Nurs Forum 22:707–710

    PubMed  CAS  Google Scholar 

  5. Vassilomanolakis M, Koumakis G, Barbounis V et al (2001) Prevention of vinorelbine phlebitis with cimetidine. A two-step design study. Support Care Cancer 9:108–111

    Article  PubMed  CAS  Google Scholar 

  6. Yoh K, Niho S, Goto K et al (2004) High body mass index correlates with increased risk of venous irritation by vinorelbine infusion. Jpn J Clin Oncol 34:206–209

    Article  PubMed  Google Scholar 

  7. Yoh K, Niho S, Goto K et al (2007) Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Lung Cancer 55:337–341

    Article  PubMed  Google Scholar 

  8. Yamada T, Egashira N, Imuta M et al (2010) Role of oxidative stress in vinorelbine-induced vascular endothelial cell injury. Free Radic Biol Med 48:120–127

    Article  PubMed  CAS  Google Scholar 

  9. Navelbine (vinorelbine) Physicians’ Desk Reference (2004) Medical Economics, Montvale

  10. Navelbine (vinorelbine) Package Insert (2007) Pierre Fabre Pharmaceuticals Parsippany

  11. Jackson A (1998) Infection control—a battle in vein: infusion phlebitis. Nurs Times 94:68–71

    PubMed  CAS  Google Scholar 

  12. Nakayama S, Matsubara N, Sakai T et al (2002) The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection—a retrospective study. Gan To Kagaku Ryoho 29:633–635

    PubMed  Google Scholar 

  13. Polovich M, White JM, Kelleher LO (2005) Chemotherapy and biotherapy guideline and recommendation for practice, 2nd edn. Oncology Nursing Society, Pittsburgh

    Google Scholar 

  14. Verso M, Agnelli G (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21:3665–3675

    Article  PubMed  Google Scholar 

  15. Beckers MM, Ruven HJ, Seldenrijk CA et al (2010) Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res 125:318–321

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Takaaki Yamada, Nobuaki Egashira, Hiroyuki Watanabe, Kenichiro Nagata, Takahisa Yano, Toshiharu Nonaka & Ryozo Oishi

Authors
  1. Takaaki Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuaki Egashira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroyuki Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenichiro Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takahisa Yano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toshiharu Nonaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ryozo Oishi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nobuaki Egashira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamada, T., Egashira, N., Watanabe, H. et al. Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention. Support Care Cancer 20, 1549–1553 (2012). https://doi.org/10.1007/s00520-011-1244-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-011-1244-3

Keywords

Search

Navigation